GAVILYTE-H

Polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride · Lupin Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GAVILYTE-H, covering 2021-05-14 to 2021-05-14. Get the full timeline:

Most recent: FDA Approved: GAVILYTE-H AND BISACODYL — Supplemental Application (Lupin Pharmaceuticals, Inc.)